Holen Sie sich die Stockscreener-App
319.84
0.12%
0.757
Schlusskurs vom Vortag:
$319.08
Offen:
$321.36
24-Stunden-Volumen:
14,947
Relative Volume:
0.08
Marktkapitalisierung:
$8.65B
Einnahmen:
$2.58B
Nettoeinkommen (Verlust:
$-778.69M
KGV:
-11.70
EPS:
-27.33
Netto-Cashflow:
$223.75M
1W Leistung:
+4.65%
1M Leistung:
+3.71%
6M Leistung:
+26.24%
1J Leistung:
-7.23%
1-Tages-Spanne:
$318.18
$326.43
1-Wochen-Bereich:
$302.25
$328.25
52-Wochen-Spanne:
$211.43
$373.69
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Firmenname
Bio Rad Laboratories Inc
Sektor
Branche
Telefon
(510) 724-7000
Adresse
1000 ALFRED NOBEL DRIVE, HERCULES
Vergleichen Sie BIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
320.49 | 8.61B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
125.41 | 219.41B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.52 | 145.84B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
366.64 | 140.43B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
97.34 | 126.52B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.95 | 49.08B | 5.88B | 1.34B | 799.60M | 2.3489 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-01 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-04-03 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-12-07 | Eingeleitet | UBS | Buy |
| 2023-06-16 | Eingeleitet | Wells Fargo | Overweight |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-01-28 | Bestätigt | Citigroup | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2018-10-17 | Eingeleitet | Goldman | Buy |
| 2018-09-20 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2018-02-16 | Herabstufung | CL King | Buy → Neutral |
| 2017-07-13 | Eingeleitet | Wells Fargo | Outperform |
| 2017-06-28 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2017-01-18 | Eingeleitet | Deutsche Bank | Hold |
| 2016-10-13 | Eingeleitet | CL King | Buy |
| 2015-05-06 | Bestätigt | Jefferies | Buy |
| 2009-12-18 | Eingeleitet | Maxim Group | Buy |
| 2009-11-06 | Eingeleitet | Jefferies & Co | Buy |
| 2009-07-17 | Eingeleitet | Soleil | Buy |
| 2007-09-26 | Eingeleitet | Banc of America Sec | Buy |
| 2007-02-23 | Herabstufung | Robert W. Baird | Outperform → Neutral |
Alle ansehen
Bio Rad Laboratories Inc Aktie (BIO) Neueste Nachrichten
Protein engineering market is set for steady growth to reach US$ - openPR.com
What insider trading reveals about Bio Rad Laboratories Inc. stockGap Up & Safe Entry Trade Reports - ulpravda.ru
Why Bio Rad Laboratories Inc. stock is trending among retail tradersOptions Play & Daily Momentum Trading Reports - ulpravda.ru
What analyst consensus says on Bio Rad Laboratories Inc. stockJuly 2025 Final Week & Consistent Growth Equity Picks - ulpravda.ru
Is Bio Rad Laboratories Inc. stock resilient to inflationMarket Growth Report & Consistent Growth Stock Picks - ulpravda.ru
Published on: 2026-01-09 02:49:47 - ulpravda.ru
How Bio Rad Laboratories Inc. Class B stock gains from tech spendingQuarterly Trade Report & Technical Confirmation Trade Alerts - ulpravda.ru
Published on: 2026-01-09 02:16:09 - ulpravda.ru
What margin trends mean for Bio Rad Laboratories Inc. stockWall Street Watch & AI Powered Market Trend Analysis - ulpravda.ru
Is Bio Rad Laboratories Inc. Class B stock attractive for growth fundsJuly 2025 Price Swings & Weekly High Momentum Picks - ulpravda.ru
Will Bio Rad Laboratories Inc. (BUW) stock enhance shareholder valueJuly 2025 Update & Real-Time Price Movement Reports - ulpravda.ru
Published on: 2026-01-08 22:32:57 - ulpravda.ru
Is Bio Rad Laboratories Inc. stock a smart buy before Fed meetingJuly 2025 Action & Free Low Drawdown Momentum Trade Ideas - ulpravda.ru
Can Bio Rad Laboratories Inc. stock sustain institutional interest2025 Price Momentum & High Accuracy Investment Signals - ulpravda.ru
Why Bio Rad Laboratories Inc. stock appeals to analystsJuly 2025 Macro Moves & Consistent Return Investment Signals - ulpravda.ru
Can Bio Rad Laboratories Inc. stock beat market expectations this quarter2025 Market WrapUp & Intraday High Probability Alerts - ulpravda.ru
$43.36 Bn Autism Spectrum Disorder Diagnostics Global Market Trends, Opportunities and Strategies, 2019-2024, 2025-2029F, 2034F - GlobeNewswire Inc.
Laboratory Supplies Market 2026 Forecast: In-Depth Industry - openPR.com
Basic Statistics in Laboratory Quality Control - Labroots
Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan's 44th Annual Healthcare Conference - BioSpace
United States In-vitro Cancer Diagnostics Market 2025 | Lead - openPR.com
Is Bio Rad Laboratories Inc. Class B stock worth buying before Fed action2026 world cup usa national team round of 16 key players pressing system group prediction insights - ulpravda.ru
Earnings Risk: Can Bio Rad Laboratories Inc stock beat market expectations this quarterJuly 2025 Big Picture & Expert Approved Momentum Trade Ideas - moha.gov.vn
Bio-Rad Laboratories, Inc. $BIO Shares Acquired by Allspring Global Investments Holdings LLC - MarketBeat
Bio-Rad Laboratories, Inc. (NYSE:BIO) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Helicobacter Pylori Diagnostics Market Forecast Through - openPR.com
Sample Preparation Market 2025 Forecast: In-Depth Industry - openPR.com
Boston Trust Walden Corp Invests $26.76 Million in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Responsive Playbooks and the BIO Inflection - Stock Traders Daily
Marathon Asset Management Ltd Sells 7,893 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Protein A Resin Market is expected to reach US$ 4.1 billion by 2032 - openPR.com
Newborn Screening Market Assessment 2032: Segment Analysis, - openPR.com
Japan's Life Sciences Research and Clinical Applications Fuel - openPR.com
BIO (Bio-Rad Laboratories) Sale Of Property, Plant, Equipme - GuruFocus
Harbor Capital Advisors Inc. Lowers Stock Holdings in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
United states DNA Forensics Market to Reach USD 5.60 Billion - openPR.com
United states IVD Quality Control Market expected to grow at - openPR.com
United states Molecular Quality Controls Market expected - openPR.com
Bio-Rad Laboratories Earnings Notes - Trefis
Robust Growth in Molecular Quality Control Market (2025-2032): - openPR.com
Exchange Traded Concepts LLC Buys 7,648 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Life Science Instruments & Consumables Market to Reach USD - openPR.com
Enzyme-Linked Immunosorbent Assay Market is expected to reach - openPR.com
BIO (Bio-Rad Laboratories) EV-to-OCF : 16.80 (As of Dec. 23, 2025) - GuruFocus
Bio-Rad Laboratories, Inc. Class A Common Stock (NY: BIO - FinancialContent
Cell Viability Assays Market Soars as Drug Discovery Demand - openPR.com
Why Bio Rad Laboratories Inc. stock attracts global investorsTrade Risk Assessment & Capital Protection Trading Alerts - Улправда
Published on: 2025-12-20 23:30:31 - Улправда
Can Bio Rad Laboratories Inc. (BUW) stock sustain margin levelsJuly 2025 PostEarnings & Risk Managed Trade Strategies - bolumsonucanavari.com
How Bio Rad Laboratories Inc. stock performs in interest rate cycles2025 Top Decliners & Capital Efficient Trading Techniques - Улправда
Published on: 2025-12-20 08:31:22 - Улправда
Finanzdaten der Bio Rad Laboratories Inc-Aktie (BIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.54%
0.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):